In-Depth Biotech Stock Research by BioNap

“Service Closed effective July 1, 2016”

Second Quarter Results Confirm Why We Like Aastrom

VCEL

On August 14, 2014, Aastrom Biosciences, Inc. (ASTM) reported financial results for the second quarter of 2014. Results included one full quarter of operations for the company's recently acquired Cell Therapy and Regenerative Medicine (CTRM) business from Sanofi (SNY), previously known as Genzyme...

On August 14, 2014, Aastrom Biosciences, Inc. (ASTM) reported financial results for the second quarter of 2014. Results included one full quarter of operations for the company's recently acquired Cell Therapy and Regenerative Medicine (CTRM) business from Sanofi (SNY), previously known as Genzyme...

This article is only available to subscribers of In-Depth Biotech Stock Research